https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 De novo and recurrent metastatic breast cancer – A systematic review of population-level changes in survival since 1995 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47983 60 years (12·7, 11·6 months). Interpretation: Population-level improvements in OS for dnMBC have not been consistently observed in rMBC cohorts nor older women. These findings have implications for counselling patients about prognosis, planning cancer services and trial stratification. Funding: SL was funded in part by a National Health and Medical Research Council (NHMRC) Project Grant ID: 1125433. NH was funded by the NBCF Chair in Breast Cancer Prevention grant (EC-21–001) and a NHMRC Investigator (Leader) grant (194410). BD and SAP were funded in part by the NHMRC Centre of Research Excellence in Medicines Intelligence (1196900).]]> Tue 14 Feb 2023 14:22:54 AEDT ]]> O⁶-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7421 Sat 24 Mar 2018 08:40:26 AEDT ]]> Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:21757 Sat 24 Mar 2018 07:53:08 AEDT ]]>